Birdwatch Note Rating
2024-05-07 13:23:02 UTC - HELPFUL
Rated by Participant: CB1A629C19B674B93854073FE11412973F23A90E5AC89A2A13021743FF8F16DD
Participant Details
Original Note:
The revocation was made at the request of AstraZeneca itself: ".... withdrawing, at the holder's request, the marketing authorisation granted by Decision C(2021) 698(final) for "Vaxzevria - COVID-19 Vaccine (ChAdOx1-S [recombinant])", a medicinal product for human use" https://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_en.pdf
All Note Details